A Recombinant fusion toxin targeted to the granulocyte-Macrophage colony-Stimulating factor receptor

References

• Sandler D. P. Epidemiology of acute myelogenous leukemia. Seminars in Oncology 1987; 14: 359–364
   PubMed Web of Science ®Google Scholar
• Rohatiner A., Lister T. A. Acute Myelogenous Leukemia in Adults. Leukemia, 6th Edition, E. S. Henderson, T. A. Lister, M. F. Greaves. W. B. Saunders, Philadelphia 1996; 479–508
   Google Scholar
• Uckun F. M., Evans W. E., Forsyth C. J., Waddick K. G., Ahlgren L. T., Chelstrom L. M., Burkhardt A., Bolen J., Myers D. E. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995; 267: 886–891
   PubMed Web of Science ®Google Scholar
• Pastan I., FitzGerald D. Recombinant toxins for cancer treatment. Science 1991; 254: 1173–1177
   PubMed Web of Science ®Google Scholar
• Vitetta E. S., Thorpe P. E. Antibodies in cancer therapy: Basic principles of monoclonal antibodies. Section 21.2: Immunotoxins. Biologic Therapy of Cancer, V. T. Devita, S. S. Hellman, S. A. Rosenberg. J.B. Lippincott Company, Philadelphia, PA 1991; 48–85
   Google Scholar
• Perentesis J. P., Kersey J. H. Biologic Therapy of Leukemia. Leukemia, 6th Edition, E. S. Henderson, T. A. Lister, M. F. Greaves. W. B. Saunders, Philadelphia 1996; 354–388
   Google Scholar
• Young D. C., Griffin J. D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1988; 68: 1178–1181
   Web of Science ®Google Scholar
• Cheng G. Y. M., Kelleher C. A., Miyauchi J., Wang C., Wong G., Clark S. C., McCulloch E. A., Minden M. D. Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood 1988; 71: 204–208
   PubMed Web of Science ®Google Scholar
• Murohashi I., Tonda S., Susuki T., Nazata K., Yamashita Y., Nara N. Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. Blood 1989; 74: 35–41
   PubMed Web of Science ®Google Scholar
• Russell N. H. Autocrine growth factors and leukaemic haemopoiesis. Blood Reviews 1992; 6: 149–156
   PubMed Web of Science ®Google Scholar
• Bradbury D., Rogers S., Kozlowski R., Bowen G., Reilly I. A. G., Russell N. H. Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia. British Journal of Haematology 1990; 76: 488–93
   PubMed Web of Science ®Google Scholar
• Bradbury D., Rogers S., Reilly I. A. G., Kozlowski R., Russell N. H. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1-beta in the autonomous growth of acute myeloblastic leukemia cells—studies using purified CD34-postive cells. Leukemia 1992; 6: 562–66
   PubMed Web of Science ®Google Scholar
• Rogers S. Y., Bradbury D., Kozlowski R., Russell N. H. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Experimental Hematology 1994; 22: 593–598
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Van Putten W. L. J., Touw I. P., Delwel R., Santini V. Autonomous growth determines prognosis in adult acute myeloid leukemia. New England Journal of Medicine 1993; 328: 614–619
   PubMed Web of Science ®Google Scholar
• Hunter A. E., Rogers S. Y., Roberts I. A. G., Barrett A. J., Russell N. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993; 82: 899–903
   PubMed Web of Science ®Google Scholar
• Yamaizumi J., Mekada E., Uchida T., Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978; 15: 245–250
   PubMed Web of Science ®Google Scholar
• Perentesis J. P., Miller S. P., Bodley J. W. Protein toxin inhibitors of protein synthesis. Biofactors 1992; 3: 173–184
   PubMed Web of Science ®Google Scholar
• Choe S., Bennett M. J., Fujii G., Curmi P. M. G., Kantafdjieff K. A., Collier R. J., Eisenberg D. The crystal structure of diphtheria toxin. Nature 1992; 357: 216–222
   PubMed Web of Science ®Google Scholar
• Bennett M. J., Choe S., Eisenberg D. Domain swap-ping: Entangling alliances between proteins. Proceedings of the National Academy of Sciences, USA 1994; 91: 3127–3131
   PubMed Web of Science ®Google Scholar
• Williams D. P., Parker K., Bacha P., Bishai W., Borowski M., Genbauffe F., Strom T. B., Murphy J. R. Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Engineering 1987; 1: 493–498
   PubMedGoogle Scholar
• Jean L. F., Murphy J. R. Diphtheria toxin receptor-binding domain substitution with interleukin 6. Genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein. Protein Engineering 1991; 4: 989–994
   PubMedGoogle Scholar
• Lakkis F., Steele A., Pacheco-Silva A., Rubin-Kelley V., Strom T. B., Murphy J. R. interleukin 4 receptor targeted cytotoxicity: Genetic construction and in vivo immunosuppresive activity of a diphtheria toxin-related murine interleukin 4 fusion protein. European Journal of Immunology 1991; 21: 2253–2258
   PubMed Web of Science ®Google Scholar
• Shaw J. P., Akiyoshi D. E., Arrigo D. A., Rhoad A. E., Sullivan B., Thomas J., Genbauffe F. G., Bacha P., Nichols J. C. Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. Journal of Biological Chemistry 1991; 266: 21118–21124
   PubMed Web of Science ®Google Scholar
• LeMaistre C. F., Meneghetti C., Rosenblum M., Reuben J., Parker K., Shaw J., Deisseroth A., Woodworth T., Parkinson D. R. Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood 1992; 79: 2547–2554
   PubMed Web of Science ®Google Scholar
• LeMaistre C. F., Craig F. E., Meneghetti C., McMullin B., Parker K., Reuben J., Boldt D. H., Rosenblum M., Woodworth T. Phase I trial of a 90-minute infusion of the fusion toxin DAB486TL-2 in hematologic cancers. Cancer Research 1993; 53: 3930–3934
   PubMed Web of Science ®Google Scholar
• Waters C. A., Schimke P. A., Snider C. E., Strom T. B., Murphy J. R. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells. European Journal of Immunology 1990; 20: 785–791
   PubMed Web of Science ®Google Scholar
• Bacha P., Williams D. P., Waters C., Murphy J. R., Strom T. B. Interleukin-2 receptor cytotoxicity: Interleukin-2 receptor mediated action of a diphtheria toxin-related interleuin-2 fusion protein. Journal of Experimental Medicine 1988; 167: 612–622
   PubMed Web of Science ®Google Scholar
• Woodworth T. G., Nichols J. C. Recombinant fusion toxins—a new class of targeted biologic therapeutics. Cancer Treatment & Research 1993; 68: 145–160
   PubMedGoogle Scholar
• Perentesis J. P., Genbauffe F. S., Veldman S. A., Galeotti C. L., Livingston D. M., Bodley J. W., Murphy J. R. Expression of diphtheria toxin fragment A and hormone-toxin fusion proteins in toxin-resistant yeast mutants. Proceedings of the National Academy of Sciences, USA 1988; 85: 8386–8390
   PubMed Web of Science ®Google Scholar
• Sambrook J., Maniatis T., Fritsch E. S. Molecular cloning: A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 1989
   Google Scholar
• Chen J., Bodley J. W., Livingston D. M. Diphtheria toxin-resistant mutants of. Saccharomyces cerevisiae, Molecular and Cellular Biology 1985; 5: 3375–3360
   Google Scholar
• Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y-F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. Journal of Cellular Physiology 1989; 140: 323–334
   PubMed Web of Science ®Google Scholar
• Collins S. J. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 1987; 70: 1233–1244
   PubMed Web of Science ®Google Scholar
• Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer 1980; 26: 171–176
   PubMed Web of Science ®Google Scholar
• Lange B. M., Valtieri M., Santoli D., Caracciolo D., Mavilio F., Gemmperlein I., Griffin C., Emanuel B., Finan J., Nowell P., Rovera G. Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192–199
   PubMed Web of Science ®Google Scholar
• Stong R. C., Korsmeyer S. J., Parkin J. L., Arthur D. C., Kersey J. H. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985; 65: 21–31
   PubMed Web of Science ®Google Scholar
• Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45: 321–324
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Mitchell J. B., Obuz V., Park C. H., Waddick K., Friedman N., Oubaha L., Min W. S., Song C. W. Radiation sensitivity of human B-lineage lymphoid precursor cells. International Journal of Radiation Oncology Biology and Physics 1991; 21: 1553–1560
   PubMed Web of Science ®Google Scholar
• Holmes K. L., Palaszynski E., Fredrickson T. N., Morse H. C., III, Ihle J. Correlation of cell-surface phenotype with the establishemnt of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms. Proceedings of the National Academy of Sciences, USA 1985; 82: 6687–6691
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. Journal of Immunologic Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ramakrishnan S., Houston L. L. Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell -specific immunotoxin containing poke-weed antiviral protein. Cancer Research 1985; 45: 69–75
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Ramakrishnan S., Houston L. L. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. Journal of Immunology 1985; 134: 2010–16
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Stong R. C., Youle R. J., Vallera D. A. Combined ex vivo treatment with immunotoxins and mafosfamid: A novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts. Journal of Immunology 1985; 134: 3504–3515
   PubMed Web of Science ®Google Scholar
• Oval J., Taetle R. Factor-dependent human leukemia cell lines: New models for regulation of acute non-lymphocytic leukemia cell growth and differentiation. Blood Reviews 1990; 4: 270–279
   PubMed Web of Science ®Google Scholar
• Naglich J. G., Metherall J. E., Russell D. W., Eidels L. Expresson cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051–1061
   PubMed Web of Science ®Google Scholar
• Diederichs K., Boone T., Karplus P. A. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. Science 1991; 254: 1779–1782
   PubMed Web of Science ®Google Scholar
• Walter M. R., Cook W. J., Ealick S. E., Nagabhushan T. L., Trotta P. P., Bugg C. E. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. Journal of Molecular Biology 1992; 224: 1075–1085
   PubMed Web of Science ®Google Scholar
• Bazan J. P. Structural design and molecular evolution of a cytokine receptor superfamily. Proceedings of the National Academy of Sciences, USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hematopoietic regulators: Redundancy or sublety. Blood 1993; 82: 3515–23
   PubMed Web of Science ®Google Scholar
• Gasson J. C. Molecular Physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 1131–1145
   PubMed Web of Science ®Google Scholar
• Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
   PubMed Web of Science ®Google Scholar
• Miyajima A., Mui L-A. F., Ogorochi T. Receptors for granulocyte-macrophage colony stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82: 1960–1974
   PubMed Web of Science ®Google Scholar
• Berardi A. C., Wang A., Levine J. D., Lopez P., Scadden D. T. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104–108
   PubMed Web of Science ®Google Scholar
• Spielholz C., Heaney M. L., Morrison M. E., Houghton A. N., Carlos Vera J., Golde D. W. Granulocyte-macrophage colony-stimulating factor signals for increased glucose uptake in human melanoma cells. Blood 1995; 85: 973–980
   PubMed Web of Science ®Google Scholar
• Baldwin G. C., Gasson J. C., Kaufman S. E., Quan S. G., Williams R. E., Avalos B. R., Gazdar A. F., Golde D. D. W., DiPersio J. F. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989; 73: 1033–1037
   PubMed Web of Science ®Google Scholar
• Berdel W. E., Danhauser-Riedl S., Steinhauser G., Winton E. F. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989; 73: 80–83
   PubMed Web of Science ®Google Scholar